Elevation Oncology, Inc.·4

Jun 21, 4:15 PM ET

Walsh Colin 4

4 · Elevation Oncology, Inc. · Filed Jun 21, 2023

Insider Transaction Report

Form 4
Period: 2023-06-16
Walsh Colin
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-16+31,23831,238 total
    Exercise: $1.47Exp: 2033-06-15Common Stock (31,238 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 100% of the total shares on the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.

Documents

2 files